Filing metadata

Accession number
0000950170-24-107411
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Sep 17, 2024
Reporting period
Sep 16, 2024
Description
Insider transaction

Explore SEC Filings Hub